Publikationen

Publikationen (peer-reviewed)

  1. Schumacher PM, Neininger MP, Kaune A, Bertsche T. Counseling patients on correct drug handling in German community pharmacies: experiences and opinions of pharmaceutical staff. Int J Clin Pharm. 2018 Nov 29. doi: 10.1007/s11096-018-0757-y. [Epub ahead of print]
  2. Neininger MP, Buchholz P, Kiess W, Siekmeyer M, Bertsche A, Bertsche T. Incompatibilities in paediatric intensive care - pitfalls in drug information. Pharmazie. 2018 1;73:605-608. doi: 10.1691/ph.2018.8585.
  3. Freyer J, Kasprick L, Sultzer R, Schiek S, Bertsche T. A dual intervention in geriatric patients to prevent drug-related problems and improve discharge management. Int J Clin Pharm. 2018;40:1189-1198. doi: 10.1007/s11096-018-0643-7.
  4. Wilke D, Schiek S, Knoth H, Bertsche T. [Medication Plans at Hospital Admission - a Multicentre Analysis Using Statutory Health Insurance Data]. Dtsch Med Wochenschr. 2018;143:e117-e124. doi: 10.1055/a-0595-6345.
  5. Fisch SM, Neininger MP, Prenzel F, Bernhard MK, Hornemann F, Merkenschlager A, Kiess W, Bertsche T, Bertsche A. Experiences, expectations, and fears of adolescents with epilepsy or bronchial asthma. Eur J Pediatr. 2018;177:1451-1457. doi: 10.1007/s00431-018-3200-4.
  6. Schumacher PM, Kaune A, Merkenschlager A, Bernhard MK, Kiess W, Neininger MP, Bertsche A, Bertsche T. Optimizing parents' performance in anticonvulsant rescue medication administration. Epilepsy Behav. 2018 Jul;84:37-43. doi:10.1016/j.yebeh.2018.02.032.
  7. Bach VA, Neininger MP, Spindler UP, Hotopp LC, Hornemann F, Syrbe S, Merkenschlager A, Kiess W, Bernhard MK, Bertsche T, Bertsche A. How do parentsperceive adverse drug events of their children's anticonvulsant medication? Eur JnPaediatr Neurol. 2018;22:427-433. doi: 10.1016/j.ejpn.2018.01.027.
  8. Dumeier HK, Richter LA, Neininger MP, Prenzel F, Kiess W, Bertsche A, Bertsche T. Knowledge of allergies and performance in epinephrine auto-injector use: a controlled intervention in preschool teachers. Eur J Pediatr. 2018;177:575-581. doi: 10.1007/s00431-017-3073-y.
  9. Bertsche T, Neininger MP, Kaune A, Schumacher PM, Dumeier HK, Bernhard MK, Syrbe S, Kiess W, Merkenschlager A, Bertsche A. [Interdisciplinary Concepts of Paediatrics and Clinical Pharmacy to Optimise Anticonvulsant Treatment]. Klin Padiatr. 2018;230:5-12. doi: 10.1055/s-0043-120525.
  10. Hotopp LC, Spindler UP, Bach VA, Hornemann F, Syrbe S, Andreas A, Merkenschlager A, Kiess W, Bernhard MK, Bertsche T, Neininger MP, Bertsche A. How do Parents Perceive the Initial Medical Consultation on their Child's Developmental Disorder? Klin Padiatr. 2018;230:44-49. doi: 10.1055/s-0043-117960.
  11. Jansen P, Neininger MP, Bernhard MK, Kiess W, Merkenschlager A, Bertsche T, Bertsche A. Knowledge and attitudes about epilepsy: A survey of high school students in Germany. Seizure. 2017 Oct;51:139-144. doi: 10.1016/j.seizure.2017.08.008.
  12. Freyer J, Hueter L, Kasprick L, Frese T, Sultzer R, Schiek S, Bertsche T. Drug-related problems in geriatric rehabilitation patients after discharge – A prevalence analysis and clinical case scenario-based pilot study. Res Social Adm Pharm. 2018;14:628-637. doi: 10.1016/j.sapharm.2017.07.009.
  13. Spindler UP, Hotopp LC, Bach VA, Hornemann F, Syrbe S, Andreas A, Merkenschlager A, Kiess W, Bernhard MK, Bertsche T, Neininger MP, Bertsche A. Seizure disorders and developmental disorders: impact on life of affected families-a structured interview. Eur J Pediatr. 2017;176:1121-1129. doi: 10.1007/s00431-017-2958-0.
  14. Dumeier HK, Neininger MP, Kaune A, Schumacher PM, Merkenschlager A, Kiess W,Bernhard MK, Bertsche T, Bertsche A. Seizure management by preschool teachers: A training concept focussing on practical skills. Seizure. 2017;50:38-42. doi: 10.1016/j.seizure.2017.06.001.
  15. Dumeier HK, Neininger MP, Bernhard MK, Merkenschlager A, Kiess W, Bertsche T, Bertsche A. Providing teachers with education on epilepsy increased their willingness to handle acute seizures in children from one to 10 years of age. Acta Paediatr. 2017;106:1811-1816. doi: 10.1111/apa.13938.
  16. Wilke D, Schiek S, Bertsche T, Knoth H. [Utilising statutory health insurance data to evaluate pharmaceutical interventions in secondary care - a pilot study]. Z Evid Fortbild Qual Gesundhwes. 2017;121:21-28. doi: 10.1016/j.zefq.2017.03.004.
  17. Zimmer J, Hartl S, Standfuß K, Möhn T, Bertsche A, Frontini R, Neininger MP, Bertsche T. Handling of hazardous drugs – effect of an innovative teaching session for nursing students. Nurse Educ Today 2017;49:72-78. doi: 10.1016/j.nedt.2016.11.002.
  18. Hoeke H, Roeder S, Bertsche T, Borte M, von Bergen M, Wissenbach DK. Assessment of maternal drug intake by urinary bio monitoring during pregnancy and postpartally until the third perinatal year. Pharmacoepidemiol Drug Saf. 2016;25:431-7. doi: 10.1002/pds.3943.
  19. Hoeke H, Roeder S, Mueller A, Bertsche T, Borte M, Rolle-Kampczyk U, von Bergen M, Wissenbach DK. Biomonitoring of prenatal analgesic intake and correlation with infantile anti-aeroallergens IgE. Allergy. 2016;71:901-6. doi: 10.1111/all.12897.
  20. Pauschek J, Bernhard MK, Syrbe S, Nickel P, Neininger MP, Merkenschlager A, Kiess W, Bertsche T, Bertsche A. Epilepsy in children and adolescents: Disease concepts, practical knowledge, and coping. Epilepsy Behav. 2016;59:77-82. doi: 10.1016/j.yebeh.2016.03.033.
  21. Kaune A*, Schumacher PM*, Hoppe SC, Syrbe S, Bernhard MK, Frontini R, Merkenschlager A, Kiess W, Neininger MP, Bertsche A, Bertsche T. (*equal) Administration of anticonvulsive rescue medication in children - discrepancies between parents’ self-reports and limited practical performance. Eur J Pediatr. 2016; 175:1139-46. doi: 10.1007/s00431-016-2750-6.
  22. Greißing C, Kössler K, Freyer J, Hüter L, Buchal P, Schiek S, Bertsche T. The status of the performance of medication reviews in German community pharmacies and assessment of the practical performance. Int J Clin Pharm. 2016;38:1425-1435. doi: 10.1007/s11096-016-0381-7.
  23. Greißing C, Buchal P, Kabitz HJ, Schuchmann M, Zantl N, Schiek S, Bertsche T. Medication and treatment adherence following hospital discharge – a study of an intervention aimed at reducing risk associated with medication change. Dsch Arztebl Int. 2016;113:749-756. doi:10.3238/arztebl.2016.0749.
  24. Schiek S, Moritz K, Seichter SJ, Ghanem M, von Salis-Soglio G, Frontini R, Bertsche T. Standardising Analgesic Administration for Nurses – A Prospective Intervention Study. Int J Clin Pharm. 2016;38:1497-1504. doi: 10.1007/s11096-016-0311-8.
  25. Pauschek J, Bernhard MK, Syrbe S, Nickel P, Neininger MP, Merkenschlager A, Kiess W, Bertsche T, Bertsche A. Response to Black R and Chin R's letter on our article "Epilepsy in children and adolescents: Disease concepts, practical knowledge, and coping". Epilepsy Behav. 2016;62:312. doi:10.1016/j.yebeh.2016.06.033.
  26. Freyer J, Greißing C, Buchal P, Kabitz HJ, Kasprick L, Schuchmann M, Sultzer R, Schiek S, Bertsche T. Discharge medication - what do patients know about their medication on discharge? Dtsch Med Wochenschr. 2016;141(15):e150-6. doi: 10.1055/s-0042-108618.
  27. Hartmann N, Neininger MP, Bernhard MK, Syrbe S, Nickel P, Merkenschlager A, Kiess W, Bertsche T, Bertsche A. Use of Complementary and Alternative Medicine (CAM) by Parents in Their Children and Adolescents with Epilepsy – Prevelance, Predictors and Parents’ Assessment. Eur J Paediatr Neurol. 2016;20:11-9. doi: 10.1016/j.ejpn.2015.11.003.
  28. Schiek S, Ghanem M, Frontini R, Hertel G, von Salis-Soglio G, Bertsche T. Pain assessment in routine care : A prospective observational study in an orthopedic unit. Schmerz. 2016;30:257-265. doi: 10.1007/s00482-016-0096-7.
  29. Zimmer J, Remane Y, Frontini R, Bertsche T. Herstellung applikationsfertiger oraler fester Zytostatika-Zubereitungen. Onkologische Pharmazeit 2016;2:24-28.
  30. Zimmer J, Niemann D, Seltmann K, Fischer L, Christiansen H, Frontini R, Kiess W‎, Neininger MP, Bertsche A, Bertsche T. Managing of oral medicines in paediatric oncology: Can a handbook and a pharmaceutical counselling intervention for patients and their parents prevent knowledge deficits? – A pilot study. Eur J Hosp Pharm. 2016;23:100–5. doi:10.1136/ejhpharm-2015-000716.
  31. Neininger MP, Ullmann M, Dahse AJ, Syrbe S, Bernhard MK, Frontini R, Kiess W, Merkenschlager A, Thome U, Bertsche T*, Bertsche A*. (*equal) Use of levetiracetam in neonates in clinical practice - a retrospective study at a German university hospital. Neuropediatrics. Neuropediatrics. 2015;46:329-334. doi: 10.1055/s-0035-1558969.
  32. Dumeier HK, Neininger MP, Bernhard MK, Syrbe S, Merkenschlager A, Zabel J, Kiess W, Bertsche T*, Bertsche A*. (*equal) Knowledge and attitudes of school teachers, preschool teachers and students in teacher training about epilepsy and emergency management of seizures. Arch Dis Child. 2015;100:851-5. doi: 10.1136/archdischild-2015-308306.
  33. Hoeke H, Roeder S, Bertsche T, Lehmann I, Borte M, von Bergen M, Wissenbach DK. Monitoring of drug intake during pregnancy by questionnaires and LC-MS/MS drug urine screening: evaluation of both monitoring methods. Drug Test Anal. 2015;7:695-702. doi:  10.1002/dta.1767.
  34. Neininger MP, Kaune A, Bertsche A, Rink J, Musiol J, Frontini R, Prenzel F, Kiess W, Bertsche T. How to improve prescription of inhaled salbutamol by providing standardised feedback on administration: a controlled intervention pilot study with follow-up. BMC Health Serv Res. 2015;15:40 [Epub]. doi: 10.1186/s12913-015-0702-x.
  35. Schiek S, Hildebrand C, Ranft D, Dürrbeck A, Ghanem M, Salis-Soglio G, Frontini R, Bertsche T. A cohort study investigating medication management by pharmacists to prevent drug-related problems in pain therapy. Eur J Hosp Pharm. 2015;22:3:156-160.
  36. Hoeke H, Roeder S, Bertsche T, Lehmann I, Borte M, von Bergen M, Wissenbach DK. Monitoring of drug intake during pregnancy by questionnaires and LC-MS/MS drug urine screening: evaluation of both monitoring methods. Drug Test Anal. 2015;7:695-702. doi: 10.1002/dta.1767.
  37. Bertsche T, Lindner S, Damm M, Frontini R, Exner C, Himmerich H. An Interdisciplinary Concept to Optimize Patient Safety - A Pilot Study. Psychiatr Prax. 2015;42:216-20. doi: 10.1055/s-0034-1387227.
  38. Niemann D, Bertsche A, Meyrath D, Koepf ED, Traiser C, Seebald K, Schmitt CP, Hoffmann GF, Haefeli WE, Bertsche T. A prospective three-step intervention study to prevent medication errors in drug handling in paediatric care. J Clin Nurs. 2015;24:101-14. doi: 10.1111/jocn.12592.
  39. Niemann D, Bertsche A, Meyrath D, Oelsner S, Ewen AL, Pickardt B, Henhapl T, Hoffmann GF, Meyburg J, Bertsche T. Drug handling in a paediatric intensive care unit - can errors be prevented by a three-step intervention? Klin Padiatr. 2014;226:62-7. doi: 10.1055/s-0033-1364030.
  40. Bertsche A, Neininger MP, Dahse AJ, Syrbe S, Bernhard MK, Frontini R, Kiess W, Bertsche T, Merkenschlager A. Initial anticonvulsant monotherapy in routine care of children and adolescents: levetiracetam fails more frequently than valproate and oxcarbazepine due to a lack of effectiveness. Eur J Pediatr. 2014;173:87-92. doi: 10.1007/s00431-013-2125-1.
  41. Sonntag D, Trebst D, Kiess W, Kapellen T, Bertsche T, Kostev K. [Off-label drug prescriptions among outpatient children and adolescents in Germany - a database analysis]. Dtsch Med Wochenschr. 2013;138:2239-45. doi: 10.1055/s-0033-1349609.
  42. Bertsche A, Dahse AJ, Neininger MP, Bernhard MK, Syrbe S, Frontini R, Kiess W, Merkenschlager A, Bertsche T. Ambulatory Care of Children Treated with Anticonvulsants - Pitfalls after Discharge from Hospital. Klin Padiatr. 2013;225:277-82. doi: 10.1055/s-0033-1345174.
  43. Trebst D, Sonntag D, Kiess W, Bertsche T, Kostev K. [Pain medication for children and adolescents in primary care]. Dtsch Med Wochenschr. 2013;138:1322-4. doi: 10.1055/s-0033-1343226.
  44. Bertsche T, Nachbar M, Fiederling J, Schmitt SPW, Kaltschmidt J, Seidling, HM, Haefeli WE. Assessment of a computerised decision support system for allergic rhino-conjunctivitis counselling in German pharmacy. Int J Clin Pharm. 2012;34:17-22. doi: 10.1007/s11096-011-9584-0.
  45. Mahler C, Jank S, Pruszydlo MG, Hermann K, Gärtner H, Kaltschmidt J, Ludt S, Bertsche T, Haefeli WE, Szecsenyi J. [HeiCare®: a project aiming to improve medication communication across health care sectors]. Dtsch Med Wochenschr. 2011;136:2239-44. doi: 10.1055/s-0031-1292036.
  46. Volodina A, Bertsche T, Kostev K, Winkler V, Haefeli WE, Becher H. Drug utilization patterns and reported health status in ethnic German migrants (Aussiedler) in Germany: a cross-sectional study. BMC Public Health. 2011;11:509. [Epub]. doi: 10.1186/1471-2458-11-509.
  47. Bertsche T, Veith C, Stahl A, Hoppe-Tichy T, Meyer FJ, Katus HA, Haefeli WE. A purging procedure for pantoprazole and 4-lumen catheters to prevent IV drug incompatibilities. Pharm World Sci. 2010;32:663-9. doi: 10.1007/s11096-010-9422-9.
  48. Seidling HM, Schmitt SPW, Bruckner T, Kaltschmidt J, Pruzydlo M, Senger C, Bertsche T, Walter-Sack I, Haefeli WE. Patient-specific electronic decision support reduces prescription of excessive doses. Qual Saf Health Care. 2010;19:e15. [Epub] doi: 10.1136/qshc.2009.033175.
  49. Bertsche T, Bertsche A, Krieg E-M, Kunz N, Bergmann K, Hanke G, Hoppe-Tichy T, Ebinger F, Haefeli WE. Prospective pilot intervention study to prevent medication errors in drugs administered to children by mouth or gastric tube: A program for nurses, physicians, and parents. Qual Saf Health Care. 2010;19:e26. [Epub] doi: 10.1136/qshc.2009.033753.
  50. Bertsche T, Pfaff J, Schiller P, Kaltschmidt J, Pruszydlo MG, Stremmel W, Walter-Sack I, Haefeli WE, Encke J. Prevention of adverse drug reactions in intensive care patients by personal intervention based on an electronic clinical decision support system. Intensive Care Med. 2010;36:665-72. doi: 10.1007/s00134-010-1778-8.
  51. Bertsche T, Askoxylakis V, Habl G, Laidig F, Kaltschmidt J, Schmitt SPW, Ghaderi H, Zabel-du Bois A, Milker-Zabel S, Debus J, Bardenheuer HJ, Haefeli WE. Multidisciplinary pain management based on computerized decision support in cancer pain patients. Pain. 2009;147:20-8. doi: 10.1016/j.pain.2009.07.009.
  52. Seidling HM, Storch CH, Bertsche T, Senger C, Kaltschmidt J, Walter-Sack I, Haefeli WE. Successful strategy to improve specificity of electronic statin-drug interaction alerts. Eur J Clin Pharmacol. 2009;65:1149-57. doi: 10.1007/s00228-009-0704-x.
  53. Jank S, Bertsche T, Schellberg D, Herzog W, Haefeli WE. The A14-scale: development and evaluation of a questionnaire for assessment of adherence and individual barriers. Pharm World Sci. 2009;31:426-31. doi: 10.1007/s11096-009-9296-x.
  54. Bertsche T, Fleischer M, Pfaff J, Encke J, Czock D, Haefeli WE. Pro-active provision of drug information as a technique to address overdosing in intensive-care patients with renal insufficiency. Eur J Clin Pharmacol. 2009;65:823-9. doi: 10.1007/s00228-009-0643-6.
  55. Bertsche T, Münck L, Mayer Y, Stahl R, Hoppe-Tichy T, Encke J, Haefeli WE. One-year follow-up on procedure to prevent i.v. drug incompatibilities in an intensive care unit. Am J Health Syst Pharm. 2009;66:1250, 1253. doi: 10.2146/ajhp090070.
  56. Bertsche T, Niemann D, Mayer Y, Ingram K, Hoppe-Tichy T, Haefeli WE. Prioritising the prevention of medication handling errors. Pharm World Sci. 2008;30:907-15. doi: 10.1007/s11096-008-9250-3.
  57. Bertsche T, Mayer Y, Stahl R, Hoppe-Tichy T, Encke J, Haefeli WE. Prevention of intravenous drug incompatibilities in an intensive care unit. Am J Health Syst Pharm. 2008;65:1834-40. doi: 10.2146/ajhp070633.
  58. Quinzler R, Bertsche T, Szecsenyi J, Haefeli WE. [Tablet splitting: do discount contracts influence prescribing quality?]. Med Klin (Munich). 2008;103:569-74. doi: 10.1007/s00063-008-1092-1.
  59. Jank S, Bertsche T, Herzog W, Haefeli WE. Patient knowledge on oral anticoagulants: results of a questionnaire survey in Germany and comparison with the literature. Int J Clin Pharmacol Ther. 2008;46:280-8.
  60. Walk SU, Bertsche T, Kaltschmidt J, Pruszydlo MG, Hoppe-Tichy T, Walter-Sack I, Haefeli WE. Rule-based standardised switching of drugs at the interface between primary and tertiary care. Eur J Clin Pharmacol. 2008;64:319-27.
  61. Bertsche T, Hammerlein A, Schulz M. German national drug information service: user satisfaction and potential positive patient outcomes. Pharm World Sci. 2007;29:167-72.
  62. Seidling HM, Al Barmawi A, Kaltschmidt J, Bertsche T, Pruszydlo MG, Haefeli WE. Detection and prevention of prescriptions with excessive doses in electronic prescribing systems. Eur J Clin Pharmacol. 2007;63:1185-92.
  63. Bertsche T, Haas M, Oberwittler H, Haefeli WE, Walter-Sack I. [Drugs during pregnancy and breastfeeding: new risk categories--antibiotics as a model]. Dtsch Med Wochenschr. 2006;131:1016-22.
  64. Laufer S, Greim C, Bertsche T. An in-vitro screening assay for the detection of inhibitors of proinflammatory cytokine synthesis: a useful tool for the development of new antiarthritic and disease modifying drugs. Osteoarthritis Cartilage. 2002;10:961-7.
  65. Boden SE, Schweizer S, Bertsche T, Dufer M, Drews G, Safayhi H. Stimulation of leukotriene synthesis in intact polymorphonuclear cells by the 5-lipoxygenase inhibitor 3-oxo-tirucallic acid. Mol Pharmacol. 2001;60:267-73.
  66. Boden SE, Bertsche T, Ammon HP, Safayhi H. MEK-1/2 inhibition prevents 5-lipoxygenase translocation in N-formylpeptide-challenged human neutrophils. Int J Biochem Cell Biol. 2000;32:1069-74.
letzte Änderung: 21.01.2019